Apple Inc. v. Proxense, LLC

Phison Electronics CorporationvsVervain, LLC

Phison Electronics has petitioned the PTAB to invalidate all ten claims of Vervain’s ‘240 NAND‑flash patent, asserting that the claims are obvious over multiple prior‑art references. The petition cites Gavens, Moshayedi and Sutardja patents and argues that pending district‑court suits do not bar institution.

Padagis US LLC et al.vsNeurelis, Inc.

Padagis seeks inter partes review of Neurelis’s 11,793,786 patent covering intranasal benzodiazepine solutions, arguing that all 27 claims are obvious over prior art and that the patent owner is estopped from contesting issues already decided in a prior IPR.

Zhuhai CosMX Battery Co., Ltd.vsNingde Amperex Technology Ltd.

Zhuhai CosMX Battery challenges Ningde Amperex’s attempt to overturn a PTAB institution of a lithium‑battery patent, arguing the parallel‑petition issue is moot and the Board’s decision was proper and efficient.

Apple Inc.vsVampire Labs, LLC

The PTAB granted institution for IPR2025-01215, allowing Apple Inc. to challenge Vampire Labs' patent 8358103.

Imperative Care, Inc.vsInari Medical, Inc. et al.

The PTAB has instituted an inter partes review of Inari Medical’s ’291 hemostasis valve patent after finding Imperative Care’s petition shows a reasonable likelihood of success. All 16 challenged claims are now under review.